A Phase I Study of ABT-199 Monotherapy in R/R Multiple Myeloma

Research Grant

Duke Scholars

Principal Investigator Cristina Gasparetto Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

AbbVie Inc.

Start Date

February 1, 2015

End Date

January 31, 2022

Administered By

Duke Cancer Institute

Awarded By

AbbVie Inc.

Start Date

February 1, 2015

End Date

January 31, 2022